HALO
Price
$50.13
Change
-$4.00 (-7.39%)
Updated
Oct 9, 01:54 PM (EDT)
26 days until earnings call
LGVN
Price
$1.83
Change
-$0.01 (-0.54%)
Updated
Oct 9, 01:58 PM (EDT)
Ad is loading...

HALO vs LGVN

Header iconHALO vs LGVN Comparison
Open Charts HALO vs LGVNBanner chart's image
Halozyme Therapeutics
Price$50.13
Change-$4.00 (-7.39%)
Volume$488
CapitalizationN/A
Longeveron
Price$1.83
Change-$0.01 (-0.54%)
Volume$2K
CapitalizationN/A
View a ticker or compare two or three
HALO vs LGVN Comparison Chart
Loading...
HALO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
HALO vs. LGVN commentary
Oct 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HALO is a StrongSell and LGVN is a StrongSell.

COMPARISON
Comparison
Oct 09, 2024
Stock price -- (HALO: $54.13 vs. LGVN: $1.83)
Brand notoriety: HALO and LGVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HALO: 153% vs. LGVN: 33%
Market capitalization -- HALO: $7.22B vs. LGVN: $27.86M
HALO [@Biotechnology] is valued at $7.22B. LGVN’s [@Biotechnology] market capitalization is $27.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HALO’s FA Score shows that 2 FA rating(s) are green whileLGVN’s FA Score has 1 green FA rating(s).

  • HALO’s FA Score: 2 green, 3 red.
  • LGVN’s FA Score: 1 green, 4 red.
According to our system of comparison, HALO is a better buy in the long-term than LGVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HALO’s TA Score shows that 4 TA indicator(s) are bullish while LGVN’s TA Score has 5 bullish TA indicator(s).

  • HALO’s TA Score: 4 bullish, 6 bearish.
  • LGVN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, LGVN is a better buy in the short-term than HALO.

Price Growth

HALO (@Biotechnology) experienced а -4.43% price change this week, while LGVN (@Biotechnology) price change was -2.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

HALO is expected to report earnings on Feb 25, 2025.

LGVN is expected to report earnings on May 10, 2024.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HALO($7.22B) has a higher market cap than LGVN($27.9M). HALO YTD gains are higher at: 46.456 vs. LGVN (-86.544). HALO has higher annual earnings (EBITDA): 520M vs. LGVN (-17.24M). HALO has more cash in the bank: 529M vs. LGVN (12.4M). LGVN has less debt than HALO: LGVN (1.75M) vs HALO (1.5B). HALO has higher revenues than LGVN: HALO (873M) vs LGVN (1.23M).
HALOLGVNHALO / LGVN
Capitalization7.22B27.9M25,867%
EBITDA520M-17.24M-3,016%
Gain YTD46.456-86.544-54%
P/E Ratio22.18N/A-
Revenue873M1.23M71,033%
Total Cash529M12.4M4,266%
Total Debt1.5B1.75M85,984%
FUNDAMENTALS RATINGS
HALO: Fundamental Ratings
HALO
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
24
SMR RATING
1..100
12
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
69
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HALOLGVN
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 6 days ago
76%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
HALO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL225.774.08
+1.84%
Apple
TSLA244.503.67
+1.52%
Tesla
SPY573.175.37
+0.95%
SPDR® S&P 500® ETF Trust
BTC.X62131.970000-104.691410
-0.17%
Bitcoin cryptocurrency
GME20.71-0.19
-0.91%
GameStop Corp

HALO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HALO has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HALO
1D Price
Change %
HALO100%
+0.52%
AXON - HALO
47%
Loosely correlated
+1.44%
CRSP - HALO
39%
Loosely correlated
-0.64%
PRME - HALO
38%
Loosely correlated
+3.56%
BEAM - HALO
37%
Loosely correlated
-0.64%
AVTE - HALO
36%
Loosely correlated
-1.44%
More

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with SRPT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
+0.55%
SRPT - LGVN
34%
Loosely correlated
+1.63%
ENTA - LGVN
34%
Loosely correlated
-4.76%
FATE - LGVN
33%
Loosely correlated
+0.49%
AXON - LGVN
30%
Poorly correlated
+1.44%
HALO - LGVN
28%
Poorly correlated
+0.52%
More